Journal of Gastroenterology

Papers
(The TQCC of Journal of Gastroenterology is 9. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-11-01 to 2025-11-01.)
ArticleCitations
Revisiting the relationship between thyroid function and metabolic dysfunction-associated steatotic liver disease in the era of resmetirom179
Corynoline protects chronic pancreatitis via binding to PSMA2 and alleviating pancreatic fibrosis92
Ratio of submucosal thickness to total bowel wall thickness as a new sonographic parameter to estimate endoscopic remission of ulcerative colitis83
Induction of ferroptosis by photodynamic therapy and enhancement of antitumor effect with ferroptosis inducers79
Clinical features and oncological outcomes of intestinal cancers associated with ulcerative colitis and Crohn’s disease59
Non-alcoholic fatty liver disease in patients with morbid obesity: the gut microbiota axis as a potential pathophysiology mechanism58
Risk of gastric and oesophageal adenocarcinoma following discontinuation of long-term proton-pump inhibitor therapy54
Artificial intelligence (AI) models for the ultrasonographic diagnosis of liver tumors and comparison of diagnostic accuracies between AI and human experts53
Integrated analysis of tertiary lymphoid structures in relation to tumor-infiltrating lymphocytes and patient survival in pancreatic ductal adenocarcinoma51
Managing radiation safety and protection in gastroenterology in Japan: insights from the REX-GI study50
High-risk population of progressive hepatic fibrosis in chronic hepatitis B patients on antiviral therapy47
Alpha-fetoprotein combined with initial tumor shape irregularity in predicting the survival of patients with advanced hepatocellular carcinoma treated with immune-checkpoint inhibitors: a retrospectiv46
Correlation between mismatch repair and survival of patients with gastric cancer after 5-FU-based adjuvant chemotherapy42
Predictive factors for the progression of primary localized stage small-bowel follicular lymphoma38
Three-dimensional chromatin landscapes in hepatocellular carcinoma associated with hepatitis B virus38
Clinicopathological features and prognosis of primary small bowel adenocarcinoma: a large multicenter analysis of the JSCCR database in Japan34
Associations between excessive supragastric belching and esophageal reflux factors in patients with PPI-refractory GERD in Japan31
Hic-5 deficiency attenuates MAFLD by inhibiting neutrophils migration via the CXCL1-CXCR2 axis30
Association between homologous recombination deficiency and time to treatment failure to platinum-based chemotherapy for pancreatic cancer by using the C-CAT database29
Considerations for evaluating antibiotic prophylaxis in cirrhotic patients with upper gastrointestinal bleeding in real-world data29
The absence of warfarin treatment and situs inversus are associated with the occurrence of hepatocellular carcinoma after Fontan surgery29
Clinical practice guidelines for duodenal cancer 202129
Clinical factors to predict changes of esophagogastric varices after sustained viral response with direct-acting antiviral therapy29
Novel subharmonic-aided pressure estimation for identifying high-risk esophagogastric varices28
Induction therapy with hepatic arterial infusion chemotherapy enhances the efficacy of lenvatinib and pd1 inhibitors in treating hepatocellular carcinoma patients with portal vein tumor thrombosis28
Reply to: Minocycline versus tetracycline in bismuth-containing quadruple therapy for Helicobacter pylori rescue treatment: a multicentre, randomized controlled trial28
Successful induction of human chemically induced liver progenitors with small molecules from damaged liver27
Immunity in digestive diseases: new drugs for inflammatory bowel disease treatment—insights from Phase II and III trials27
Body mass index and survival among patients with advanced biliary tract cancer: a single-institutional study with nationwide data-based validation26
Persistent body-weight change on achalasia and peroral endoscopic myotomy: a multicenter cohort study26
Anxiety and behavioral changes in Japanese patients with inflammatory bowel disease due to COVID-19 pandemic: a national survey25
Acknowledgements24
Correction: Fungal mycobiome dysbiosis in choledocholithiasis concurrent with cholangitis24
Treatment escalation and de-escalation decisions in Crohn’s disease: Delphi consensus recommendations from Japan, 202123
Evaluation of cholecystectomy in older individuals using real-world data: a multilevel analysis based on a nationwide administrative database in Japan23
Optimising carotegrast methyl use in ulcerative colitis: patient profiling, predictive biomarkers, and timing of efficacy evaluation (ASPECT study)23
Alcohol-associated liver disease increases the risk of muscle loss and mortality in patients with cirrhosis23
Expert consensus on vaccination in patients with inflammatory bowel disease in Japan23
What is the appropriate method of pathological specimen collection for cholangiocarcinoma detection in primary sclerosing cholangitis?22
Current status and trends in ERCP and post-ERCP pancreatitis in Japan: a nationwide observational study22
A study for every second day administration of vonoprazan for maintenance treatment of erosive GERD (ESD von GERD): a multicenter randomized cross-over study21
Trends of hepatitis B virus genotype distribution in chronic hepatitis B patients in Japan21
Is it necessary for endoscopic surveillance for achalasia patients?20
Circulating miR-485-3p as a biomarker for VEGF-associated therapeutic response to atezolizumab plus bevacizumab in hepatocellular carcinoma19
Proton pump inhibitor use and risk of pneumonia: a self-controlled case series study19
Targeting autophagy as a therapeutic strategy against pancreatic cancer19
Ursodeoxycholic acid for the prevention of gallstones and subsequent cholecystectomy after bariatric surgery: a meta-analysis of randomized controlled trials19
Utility of artificial intelligence with deep learning of hematoxylin and eosin-stained whole slide images to predict lymph node metastasis in T1 colorectal cancer using endoscopically resected specime19
Nationwide cohort study identifies clinical outcomes of angioectasia in patients with acute hematochezia19
Real-world efficacy and safety of glecaprevir/pibrentasvir in Japanese adolescents with chronic hepatitis C: a prospective multicenter study19
Clinical trajectory of intraductal papillary mucinous neoplasms progressing to pancreatic carcinomas during long-term surveillance: a prospective series of 100 carcinoma cases18
Reply to “Considerations for evaluating antibiotic prophylaxis in cirrhotic patients with upper gastrointestinal bleeding in real-world data”18
Interim analysis of a multicenter registry study of COVID-19 patients with inflammatory bowel disease in Japan (J-COSMOS)18
“Pathologist-independent” strategy for T1 colorectal cancer after endoscopic resection18
RTP4 silencing provokes tumor-intrinsic resistance to immune checkpoint blockade in colorectal cancer18
Discrepancies in reported gastrointestinal symptoms in Japanese hospitalized patients with COVID-1918
Cancer pathways in serrated polyposis syndrome: is conventional more crucial than serrated?17
Gastric cancer and genomics: review of literature17
VPS45 promotes the progression of hepatocellular carcinoma by recycling β1 integrin to the cell membrane via the endocytic pathway17
Nationwide estimates of patient numbers and prevalence rates of ulcerative colitis and Crohn’s disease in Japan in 202316
Characteristics, outcomes, and risk factors of surgery for acute lower gastrointestinal bleeding: nationwide cohort study of 10,342 hematochezia cases16
Correction: Partial splenic embolization combined with endoscopic therapies and vasoconstrictive drugs reduces rebleeding in cirrhosis patients with acute variceal bleeding and hypersplenism: a multic16
Effect of blood product transfusion on the prognosis of patients undergoing hepatectomy for hepatocellular carcinoma: a propensity score matching analysis16
Reply to “promising modality for severe ulcerative colitis: infliximab and plant-based diet as first-line (IPF) therapy”16
Current status of primary liver cancer and decompensated cirrhosis in Japan: launch of a nationwide registry for advanced liver diseases (REAL)16
Frequency of lymph node metastasis according to tumor location in clinical T1 early gastric cancer: supplementary analysis of the Japan Clinical Oncology Group study (JCOG0912)15
Molecular imaging of gastrointestinal stromal tumor using anti-c-KIT antibody and its fragments15
Identification of novel plasma proteins as promising noninvasive biomarker for early diagnosis and surveillance of pancreatic ductal adenocarcinoma15
Standard versus delayed initiation of S-1 adjuvant chemotherapy after surgery for pancreatic cancer: a secondary analysis of a nationwide cohort by the Japan Pancreas Society14
AI-assisted diagnosis of Helicobacter pylori infection: strengths, limitations, and future directions14
The epidemiology of rare types of hepatobiliary and pancreatic cancer from national cancer registry14
Risk of gastric and oesophageal adenocarcinomas following discontinuation of long-term proton-pump inhibitor therapy14
Impact of ursodeoxycholic acid treatment on Fontan-associated liver disease14
Quantitative measurements of M2BPGi depend on liver fibrosis and inflammation14
Post-marketing surveillance of tofacitinib in patients with ulcerative colitis in Japan: a final report of safety and effectiveness data13
Correction: Urinary dipeptidase 1 and trefoil factor 1 are promising biomarkers for early diagnosis of colorectal cancer13
The external validation of Dallas Steatosis Index among Asian population: a useful tool for metabolic dysfunction-associated steatotic liver disease identification and prevention13
Clinical outcome after cessation of nucleos(t)ide analog treatment in chronic hepatitis B patients who achieved HBsAg seroclearance13
Correction to: Composite detection rate as an upper gastrointestinal endoscopy quality measure correlating with detection of neoplasia13
Novel scale for evaluating the therapeutic efficacy of per-oral endoscopic myotomy in achalasia13
Efficacy, tolerability, and safety of oral sulfate tablet versus 2 L-polyethylene glycol/ascorbate for bowel preparation in older patients: prospective, multicenter, investigator single-blinded, rando13
Treatment strategy after noncurative endoscopic resection for early gastric cancers in patients aged ≥ 85 years: a multicenter retrospective study in a highly aged area of Japan13
The role of stromal BMP/CXCL12 signaling axis in serrated polyp development13
Characteristics of colorectal neuroendocrine tumors in patients prospectively enrolled in a Japanese multicenter study: a first report from the C-NET STUDY12
Validation of novel scoring systems for acute decompensated cirrhosis identifies PBC as an independent poor prognostic factor: a single-center Japanese cohort study12
Efficacy of endoscopic ultrasound-guided tissue acquisition for solid pancreatic lesions 20 mm or less in diameter suspected as neuroendocrine tumors or requiring differentiation12
Acute kidney injury development is associated with mortality in Japanese patients with cirrhosis: impact of amino acid imbalance12
Serum zinc levels as predictors of covert hepatic encephalopathy in patients with liver cirrhosis12
Prevalence of colonoscopy in Japan using a large-scale health claims data compared to esophagogastroduodenoscopy12
Adjuvant immune checkpoint inhibitors associated with higher recurrence-free survival in postoperative hepatocellular carcinoma (PREVENT): a prospective, multicentric cohort study12
Development of a novel oncolytic adenovirus controlled by CDX2 promoter for esophageal adenocarcinoma therapy12
Renal manifestations in inflammatory bowel disease: a systematic review11
Definitive-dose adjuvant radiotherapy following endoscopic submucosal dissection for superficial esophageal cancer11
Serum IL-6 concentration is a useful biomarker to predict the efficacy of atezolizumab plus bevacizumab in patients with hepatocellular carcinoma11
Clinical development of a blood biomarker using apolipoprotein-A2 isoforms for early detection of pancreatic cancer11
Correction: Nrf2/ASPM axis regulated vasculogenic mimicry formation in hepatocellular carcinoma under hypoxia11
Acknowledgements11
Anti-integrin αvβ6 autoantibodies in patients with primary sclerosing cholangitis11
Anti-integrin αvβ6 antibody as a biomarker for diagnosing ulcerative colitis: a nationwide multicenter validation study11
Pro- and anti-inflammatory roles of interleukin (IL)-33, IL-36, and IL-38 in inflammatory bowel disease11
A review on the current status and definitions of activity indices in inflammatory bowel disease: how to use indices for precise evaluation11
Publisher Correction: Anti-integrin αvβ6 antibody as a biomarker for diagnosing ulcerative colitis: a nationwide multicenter validation study11
Nrf2/ASPM axis regulated vasculogenic mimicry formation in hepatocellular carcinoma under hypoxia11
Proposal of discontinuation criteria of atezolizumab plus bevacizumab after curative conversion therapy for unresectable early-to-intermediate-stage hepatocellular carcinoma: a multicenter proof-of-co11
The biochemical pattern defines MASLD phenotypes linked to distinct histology and prognosis11
Correction to: Epigenetic regulation of pancreatic adenocarcinoma in the era of cancer immunotherapy10
Response to letter to the editor regarding: “Alcohol-associated liver disease increases the risk of muscle reduction and mortality in patients with cirrhosis”10
Metabolic dysfunction-associated steatotic liver disease affects the development of hepatocellular carcinoma after sustained virologic response in chronic hepatitis C patients10
Letter to "The potential of an artificial intelligence for diagnosing MRI images in rectal cancer: multicenter collaborative trial"9
Urinary dipeptidase 1 and trefoil factor 1 are promising biomarkers for early diagnosis of colorectal cancer9
The antiferroptotic effect of indigo on ulcerative colitis9
Association of ulcerative colitis symptom severity and proctocolectomy with multidimensional patient-reported outcomes: a cross-sectional study9
Growing evidence on the highly sensitive iTACT assay of hepatitis B core-related antigen for predicting hepatitis B virus reactivation9
Acknowledgements9
FGFR2 fusions assessed by NGS, FISH, and immunohistochemistry in intrahepatic cholangiocarcinoma9
The impact of the COVID-19 pandemic on the diagnosis, stage, and treatment of esophagogastric cancer9
Activating KRAS and GNAS mutations in heterotopic submucosal glands of the stomach9
Development of a capsule endoscopy scoring system for the early diagnosis of small bowel Crohn’s disease9
Current status of type 1 (IgG4-related) autoimmune pancreatitis9
Reply to “Discrepancies in reported gastrointestinal symptoms in Japanese hospitalized patients with COVID-19”9
Posttreatment serum CXCL10 level stratifies survival in compensated and decompensated cirrhotic patients due to chronic hepatitis C virus infection after direct-acting antiviral therapy9
Estimating cancer risk in immune-mediated inflammatory diseases exposed to varying doses of tumour necrosis factor inhibitors9
Mutant GNAS limits tumor aggressiveness in established pancreatic cancer via antagonizing the KRAS-pathway9
Clarifying diagnostic scope and future perspectives in AI-assisted diagnosis of Helicobacter pylori infection9
Optimal direct oral anticoagulant for upper gastrointestinal endoscopic submucosal dissection9
0.067966938018799